Login/Sign Up
MRP ₹15000
(Inclusive of all Taxes)
₹2250.0 Cashback (15%)
Provide Delivery Location
Online payment accepted
Whats That
About Cfara 20 mg Injection 20 ml
Cfara 20 mg Injection 20 ml is an anti-cancer medicine used in pediatric patients aged 1 - 21 years for the treatment of acute lymphoblastic leukaemia, a blood cancer that primarily affects the blood and bone marrow. Cfara 20 mg Injection 20 ml is used in patients with relapsed or refractory acute lymphoblastic leukaemia (ALL) after receiving at least two prior therapies.
Cfara 20 mg Injection 20 ml contains Clofarabine as an active ingredient in the class of antimetabolites. It works by inhibiting the DNA polymerase enzyme responsible for DNA elongation, synthesis, and repair.
Cfara 20 mg Injection 20 ml may cause certain side effects, such as skin rash, fatigue, headache, decreased platelet count, nausea, vomiting, diarrhoea, fever, anxiety, flushing, and injection site reactions. These side effects do not require medical attention and gradually resolve over time. A trained oncologist will administer Cfara 20 mg Injection 20 ml. Do not self-administer.
Cfara 20 mg Injection 20 ml should be avoided if you are allergic to it or any other components present in it. It should be used with caution in patients with a pre-existing or history of liver/kidney disease, gastrointestinal disorders, skin problems, and bleeding disorders, as it may cause serious side effects or worsen such conditions. This medicine is known to cause embryo-fetal toxicity. It is not recommended for use in pregnancy or breastfeeding.
Uses of Cfara 20 mg Injection 20 ml
Directions for Use
Medicinal Benefits
Cfara 20 mg Injection 20 ml contains Clofarabine, which is used in the treatment of acute lymphoblastic leukemia (ALL). It works by inhibiting the DNA polymerase enzyme that is responsible for DNA elongation, synthesis, and repair. In general, it inhibits the production of genetic material (DNA) in the cancer cells that are essential for cell growth, repair and multiplication. Thus, Cfara 20 mg Injection 20 ml stops the multiplication of abnormal cells, leads to the growth of cells in an unbalanced way and causes the death of cells.
Storage
Drug Warnings
Cfara 20 mg Injection 20 ml should be avoided if you are allergic to it or any other components present in it. Before receiving, if the child has/had any history of liver/kidney disease, gastrointestinal disorders, skin problems, and bleeding disorders, as it may cause serious side effects or worsen such conditions. This medicine is known to cause embryo-fetal toxicity. Hence, inform your doctor if you are pregnant or are planning to become pregnant before starting the treatment. Breastfeeding should be discontinued in nursing mothers during the treatment. Cfara 20 mg Injection 20 ml is given in children above one year of age only if prescribed by the doctor. Cfara 20 mg Injection 20 ml may cause myelosuppression, QT prolongation, hepatotoxicity, renal toxicity, cerebral, gastrointestinal and pulmonary haemorrhage, Tumor Lysis syndrome, severe infections, Systemic Inflammatory Response Syndrome (SIRS), enterocolitis, and skin reactions in some patients. Hence, inform your doctor about your complete medical and medication history before receiving this medicine.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Side Effects of Cfara 20 mg Injection 20 ml
Habit Forming
Therapeutic Class
Product Substitutes
We provide you with authentic, trustworthy and relevant information
Drug-Diseases Interactions
Login/Sign Up
Cfara 20 mg Injection 20 ml contains Clofarabine, which works by inhibiting the DNA transcription that is essential for cancer cell growth. This helps prevent the growth and further spread of cancerous or non-cancerous cells.
Cfara 20 mg Injection 20 ml is used only in children and adolescents 1-21 years. It is not recommended for adults.
Treatment with Cfara 20 mg Injection 20 ml may result in cerebral, gastric, and pulmonary hemorrhage that is severe and fatal. Keep track of platelets and coagulation parameters and treat as needed.
Drug-Drug Interactions Checker List
Special Advise
Disease/Condition Glossary
Acute Lymphoblastic Leukemia (ALL): Leukemia, also known as blood cancer, is a cancer of blood cells or blood-forming tissues. It causes excessive production of immature white blood cells by the bone marrow and reduces the body’s ability to fight infections. There are different types of blood cancers. ALL is a type of blood cancer that primarily affects your blood and bone marrow. It mainly targets the white blood cells, which can interfere with your body’s ability to combat infections. Symptoms may include fever, weight loss, abnormal blood cell count, bruising, and loss of appetite.
Have a query?
Buy best Neoplastic Disorders products by
Intas Pharmaceuticals Ltd
Natco Pharma Ltd
Dr Reddy's Laboratories Ltd
Cipla Ltd
Celon Laboratories Pvt Ltd
Sun Pharmaceutical Industries Ltd
Alkem Laboratories Ltd
United Biotech Pvt Ltd
Zydus Cadila
Zydus Healthcare Ltd
Neon Laboratories Ltd
Glenmark Pharmaceuticals Ltd
Mylan Pharmaceuticals Pvt Ltd
BDR Pharmaceuticals Internationals Pvt Ltd
Emcure Pharmaceuticals Ltd
Adley Formulations
Samarth Life Sciences Pvt Ltd
Hetero Drugs Ltd
Torrent Pharmaceuticals Ltd
Fresenius Kabi India Pvt Ltd
Pfizer Ltd
Admac Lifesciences(Oncology)
Adley Pharmaceuticals Ltd
Novartis India Ltd
Halsted Pharma Pvt Ltd
Getwell Life Sciences India Pvt Ltd
Lupin Ltd
Cadila Healthcare Ltd
Hetero Healthcare Pvt Ltd
GLS Pharma Ltd
Reliance Formulation Pvt Ltd
Abbott India Ltd
Aimcad Biotech Pvt Ltd
Astra Zeneca Pharma India Ltd
Therdose Pharma Pvt Ltd
Axiommax Oncology Pvt Ltd
Biochem Pharmaceutical Industries Ltd
Khandelwal Laboratories Pvt Ltd
Msn Laboratories Pvt Ltd
Aureate Healthcare
Caitlin Oncology
Dabur India Ltd
Zee Laboratories Ltd
Sarabhai Chemicals (India) Pvt Ltd
Wembrace Biopharma Pvt Ltd
Delarc Pharmaceuticals Pvt Ltd
Medaegis Biotek Pvt Ltd
Panacea Biotec Ltd
RPG Life Sciences Ltd
Shilpa Medicare Ltd
Getwell Oncology Pvt Ltd
Ipca Laboratories Ltd
Miracalus Pharma Pvt Ltd
Biocon Ltd
Cadila Pharmaceuticals Ltd
Eli Lilly and Company (India) Pvt Ltd
Ferring Pharmaceuticals Pvt Ltd
Fresenius Kabi Oncology Ltd
Getwell Pharmaceutical Pvt Ltd
Maximal Healthcare Pvt Ltd
Boehringer Ingelheim India Pvt Ltd
Del Trade International Pvt Ltd
Sayre Therapeutics Pvt Ltd
Akumentis Healthcare Ltd
Corona Remedies Pvt Ltd
Eisai Pharmaceuticals India Pvt Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Hilfen Pharmaceuticals Pvt Ltd
Johnson & Johnson Pvt Ltd
Mankind Pharma Pvt Ltd
Merck Ltd
Oncostar Pharma Pvt Ltd
Rhone Poulenc Rorer India Pvt Ltd
Vhb Life Sciences Inc
Zuventus Healthcare Ltd
Admac Pharma Ltd
Adonis Laboratories Pvt Ltd
Alniche Life Sciences Pvt Ltd
BPRL Pvt Ltd
Caitlin Life Care
Dr Care
German Remedies Ltd
Janssen Pharmaceuticals Pvt Ltd
MEDICAMEN BIOTECH LTD
Maxis Healthcare (I) Pvt Ltd
Pharm Products Pvt Ltd
Accord Life Spec Pvt Ltd
Amps Biotech Biotech Pvt Ltd
Aphia Healthcare
Astellas Pharma India Pvt Ltd
Bangalore Pharmaceutical and Research Laboratory Pvt Ltd (BPRL)
Bharat Serums and Vaccines Ltd
Cellgen Biopharma
Cosmic Life Sciences
Daris Biocare
East West Pharma India Pvt Ltd
Hillrock Biotech Pvt Ltd
Lucien Life Sciences
Maneesh Pharmaceuticals Ltd
Medilief Bioscience Pvt Ltd
Alcohol
Unsafe
Avoid consuming alcohol while on treatment with Cfara 20 mg Injection 20 ml as it may cause severe side effects.
Pregnancy
Unsafe
Cfara 20 mg Injection 20 ml is not recommended for use in pregnancy as it may cause embryo-fetal toxicity and harm your foetus. Hence, if you are under 21 and pregnant or planning pregnancy, inform your doctor before receiving Cfara 20 mg Injection 20 ml. You should not become pregnant while you are taking Cfara 20 mg Injection 20 ml. Using effective birth control methods while on treatment is suggested.
Breast Feeding
Unsafe
There are no data on the presence of clofarabine in human milk, its effects on breastfed children, or its impact on milk supply; due to the possibility of serious adverse events in breastfed children, including genotoxicity, patients are advised not to breastfeed during therapy and for at least two weeks following the final dosage.
Driving
Not applicable
Cfara 20 mg Injection 20 ml is administered to hospitalized patients.
Liver
Caution
Cfara 20 mg Injection 20 ml has not been studied in patients with liver impairment. However, inform your doctor if you have liver problems.
Kidney
Caution
If you have a history of kidney disease or have a pre-existing condition, notify your doctor before getting Cfara 20 mg Injection 20 ml. Based on your situation, your doctor may adjust the dose of this medication or prescribe a suitable alternative. Cfara 20 mg Injection 20 ml has the potential to cause renal toxicity, which presents as high creatinine levels and sudden renal failure. Monitor renal function and adjust or discontinue Clolar as needed.
Children
Safe if prescribed
Cfara 20 mg Injection 20 ml is recommended for children and adolescents below 21 years of age only if prescribed by the oncologist.